1. Larimer, F W, Perry, J R, Hardigree, A A. . The REV1 gene of Saccharomyces cerevisiae: isolation, sequence, and functional analysis. In Journal of bacteriology, 171, 230-7. doi:. https://pubmed.ncbi.nlm.nih.gov/2492497/
2. Sasatani, Megumi, Zaharieva, Elena Karamfilova, Kamiya, Kenji. 2020. The in vivo role of Rev1 in mutagenesis and carcinogenesis. In Genes and environment : the official journal of the Japanese Environmental Mutagen Society, 42, 9. doi:10.1186/s41021-020-0148-1. https://pubmed.ncbi.nlm.nih.gov/32161626/
3. Langer, Simon M, Hopfensperger, Kristina, Iyer, Shilpa S, Hahn, Beatrice H, Sauter, Daniel. 2015. A Naturally Occurring rev1-vpu Fusion Gene Does Not Confer a Fitness Advantage to HIV-1. In PloS one, 10, e0142118. doi:10.1371/journal.pone.0142118. https://pubmed.ncbi.nlm.nih.gov/26554585/
4. Zhu, Ning, Fang, Xuefeng, Li, Dan, Wang, Juan, Yuan, Ying. 2021. Identification and prognostic analysis of the cetuximab resistance-related gene REV1 in RAS wild-type metastatic colorectal cancer. In American journal of cancer research, 11, 2769-2781. doi:. https://pubmed.ncbi.nlm.nih.gov/34249427/
5. Zhu, Ning, Zhao, Yingxin, Mi, Mi, Weng, Shanshan, Yuan, Ying. 2022. REV1: A novel biomarker and potential therapeutic target for various cancers. In Frontiers in genetics, 13, 997970. doi:10.3389/fgene.2022.997970. https://pubmed.ncbi.nlm.nih.gov/36246647/
6. Petljak, Mia, Dananberg, Alexandra, Chu, Kevan, Stratton, Michael R, Maciejowski, John. 2022. Mechanisms of APOBEC3 mutagenesis in human cancer cells. In Nature, 607, 799-807. doi:10.1038/s41586-022-04972-y. https://pubmed.ncbi.nlm.nih.gov/35859169/
智鼠故事 
